Accessing Malaysian Clinical Practice Guidelines
Malaysian clinical practice guidelines (CPGs) are primarily developed and published by the Ministry of Health Malaysia and can be accessed through the official Malaysian Health Technology Assessment Section (MaHTAS) portal and the Academy of Medicine Malaysia website.
Primary Access Points
The main repository for Malaysian CPGs is maintained by:
- Ministry of Health Malaysia - MaHTAS (Malaysian Health Technology Assessment Section): This is the official government body responsible for developing evidence-based CPGs for the Malaysian healthcare system
- Academy of Medicine Malaysia: Publishes specialty-specific guidelines and provides access to various clinical practice guidelines
Development Process
Malaysian CPGs are developed using rigorous evidence-based methodologies. The ADAPTE trans-contextual adaptation framework is commonly employed, which allows for adaptation of international guidelines to the Malaysian context when local evidence is limited 1. This process involves:
- Systematic searches of international guideline repositories
- Quality assessment using AGREE II tool
- Multidisciplinary expert panels evaluating currency and content
- Adaptation of recommendations for local applicability
Examples of Available Malaysian CPGs
Evidence demonstrates active development and implementation of Malaysian CPGs across multiple clinical areas:
- Dengue Management: The Malaysian Dengue CPG (revised 2nd edition) provides evidence-based guidance for dengue infection management, with documented awareness among clinicians 2, 3
- Major Depressive Disorder: The Malaysian CPG on Management of Major Depressive Disorder (2nd edition, 2019) covers screening, diagnosis, treatment, and referral in primary care settings 4, 5
- Dental Caries Management: Developed through ADAPTE framework with 21 final recommendations 1
Implementation Considerations
Important caveat: While Malaysian CPGs exist and show good awareness among healthcare providers, adherence varies significantly. Studies show adherence rates ranging from 7.1% to 100% depending on the specific recommendation and clinical setting 3. Barriers to implementation include time constraints, resource limitations, and gaps in clinical training 2, 4.
For privately practicing physicians, awareness of CPG existence can be as low as 50%, highlighting the need for improved dissemination strategies 4.
Pan-Asian Adapted Guidelines
Malaysia also participates in Pan-Asian adaptations of international guidelines (particularly ESMO guidelines) for oncology conditions, where Malaysian experts contribute to regional consensus statements for lung cancer 6, 7, gastric cancer 8, hepatocellular carcinoma 9, and esophageal cancer 10.